Insider Trading June 16, 2026 04:58 PM

Fairholme Funds Divest $12.08M in ST JOE Co Holdings Amid Mixed Quarterly Results

Bruce Berkowitz's investment vehicle reduces stake in the real estate developer as the company reports revenue growth offset by declining net income.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
JOE

Bruce R. Berkowitz, a significant shareholder in ST JOE Co (NASDAQ:JOE), and Fairholme Funds Inc. have executed a series of share sales totaling approximately $12.08 million. The transactions, documented in a recent Securities and Exchange Commission filing, occurred over three consecutive trading days in mid-June. This divestment comes as the real estate company navigates a complex financial landscape, characterized by recent quarterly results that show a divergence between top-line growth and bottom-line performance.

Fairholme Funds Divest $12.08M in ST JOE Co Holdings Amid Mixed Quarterly Results
JOE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Bruce R. Berkowitz and Fairholme Funds Inc. sold 184,700 shares of ST JOE Co for approximately $12.08 million in mid-June 2026.
  • ST JOE Co reported a 5% revenue increase to $99.1 million in Q1 2026, but net income declined by 21% due to reduced joint venture equity income.
  • The company maintains a perfect Piotroski Score of 9, indicating strong financial health despite the recent earnings decline.

The recent SEC filing details a strategic reduction in holdings by Bruce R. Berkowitz, who holds a 10% ownership stake in ST JOE Co, alongside Fairholme Funds Inc. The collective action resulted in the liquidation of 184,700 shares of the real estate developer's common stock. The sales were executed over a concentrated period in mid-June, with transaction prices fluctuating between $65.03 and $65.59 per share. This activity stands in contrast to the stock's recent market trajectory, which has appreciated by 41% over the past year, currently trading at $64.42. Despite this upward momentum, analytical assessments suggest the shares may be trading at levels that exceed their intrinsic value.

The specific breakdown of the sales reveals a methodical approach to the divestment. On June 12, 2026, 63,800 shares were sold at a price of $65.25 per share. Two days later, on June 15, 2026, a larger block of 94,200 shares was offloaded at $65.59 per share. The series concluded on June 16, 2026, with the sale of 26,700 shares at $65.03 per share. These transactions were facilitated by The Fairholme Fund, a series within Fairholme Funds, Inc. Mr. Berkowitz, through his control of Fairholme Capital Management, LLC, serves as the investment manager for the fund. Both Mr. Berkowitz and Fairholme Funds Inc. have formally disclaimed beneficial ownership of the sold securities, limiting their interest to any pecuniary gain. Following these reductions, The Fairholme Fund retains a substantial position of 15,214,024 shares of ST JOE Co common stock. Separately, Mr. Berkowitz maintains a direct holding of 606,866 shares.

While the insider selling activity draws attention, the underlying financial health of ST JOE Co presents a mixed narrative. The company recently reported its first-quarter 2026 earnings, revealing a 5% increase in revenue, which reached $99.1 million compared to the prior year. However, this top-line growth was offset by a significant 21% decline in net income. This contraction in profitability is largely attributed to reduced equity income derived from joint ventures. The Piotroski Score, a metric used to assess financial strength, remains perfect at 9, indicating robust operational fundamentals. Despite this strong score, the disparity between revenue growth and income decline highlights the challenges the company faces in translating operational activity into net profitability.

The recent performance of ST JOE Co underscores the intricate relationship between revenue generation and equity income in the real estate sector. The company's ability to maintain a perfect Piotroski Score amidst declining net income suggests a resilient balance sheet, yet the reliance on joint venture contributions remains a critical factor for future financial stability. Investors are closely monitoring how these dynamics will influence the company's valuation and market perception in the coming quarters.

Risks

  • The significant decline in net income, driven by reduced equity income from joint ventures, poses a risk to the company's profitability and investor confidence.
  • Analytical assessments suggest ST JOE Co shares may be overvalued at current levels, despite the stock's 41% appreciation over the past year.
  • The company's financial health is heavily influenced by joint venture contributions, creating uncertainty around future income streams and overall performance.

More from Insider Trading

Globe Life Executive Dolores Skarjune Executes $693K Stock Sale Following Strong Rally Jun 16, 2026 Gilead Sciences Executive Disposes of $371K in Shares Amid HIV Drug Pipeline Progress Jun 16, 2026 Ra Capital Management Cuts Werewolf Therapeutics Holding by $173,757 Jun 16, 2026 Amprius Technologies Director Offloads $1.46M in Shares Amid Market Volatility and Corporate Developments Jun 16, 2026 Venture Global's General Counsel Offloads $12.8M in Shares Amid Market Shifts Jun 16, 2026